FDA approves Covid-19 test that uses CRISPR gene-editing technology
By Joel Achenbach, Laurie McGinley | Published May 8, 2020
The FDA approved a new diagnostic tool that employs the revolutionary CRISPR gene-editing technology to determine in just one hour if someone is infected with the novel coronavirus.